Supplementary Table 1 from Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC

crossref(2024)

引用 0|浏览6
暂无评分
摘要

The EGFR mutation status of patient-derived models using whole exome sequencing analysis

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要